Astera Labs (NASDAQ: ALAB) Posts $392.4M Q2 Revenue, Doubling Year-Over-Year
Alpha Stocks Insight Staff
Independent stock news and analysis covering NASDAQ and NYSE markets.
Revenue doubled to $392.4M in Q2 2026, and Q3 guidance of $540M-$560M indicates the growth pace is accelerating, not slowing.
Astera Labs (NASDAQ: ALAB) reported Q2 2026 revenue of $392.4 million, up 104% year-over-year and 27% sequentially from $308 million in the prior quarter, marking a record for the company. GAAP net income reached $153.1 million, while GAAP diluted EPS came in at $0.83 and non-GAAP diluted EPS at $0.80. Shares gained 12.65% on Tuesday, August 4, while the S&P 500 rose 1.80%.
Q2 2026 Financial Results
- Revenue: $392.4 million, up 104% year-over-year
- GAAP gross margin: 73.3% for the quarter ended June 30, 2026
- GAAP operating income: $89.2 million, representing a 22.7% operating margin
- Non-GAAP operating income: $153.5 million, a 39.1% non-GAAP operating margin
- GAAP net income: $153.1 million; Non-GAAP net income: $145.8 million
- GAAP diluted EPS: $0.83; Non-GAAP diluted EPS: $0.80
What Drove the Results
The company cited diversified growth across its AI fabrics and signal conditioning product lines, with its Aries product family posting a record quarterly revenue figure. CEO Jitendra Mohan noted the Scorpio fabric switch family is expected to become the company's largest product line in Q3, one quarter ahead of prior internal expectations, a milestone he described as marking Astera Labs' evolution into a complete AI fabric infrastructure provider.
On the product side, the quarter included expansion of the Taurus signal conditioning portfolio to include 3.2T Smart Retimers and Smart Redrivers for 224G Ethernet and UALink connectivity. The company also showcased its Scorpio X-Series 320-lane Smart Fabric Switch publicly at Computex 2026 in Taiwan and demonstrated joint architectures with AMD at the Advancing AI 2026 event, covering PCIe, CXL, and Ethernet configurations.
The divergence between GAAP net income of $153.1 million and non-GAAP net income of $145.8 million reflects stock-based compensation and related non-cash adjustments that the company excludes from its non-GAAP figures. The GAAP figure in this instance exceeded the non-GAAP figure, reflecting discrete tax items that are excluded from the non-GAAP calculation.
Q3 2026 Guidance
Astera Labs guided Q3 2026 revenue to a range of $540 million to $560 million, a sequential increase of roughly 38% to 43% at the midpoint from Q2's $392.4 million. GAAP diluted EPS guidance stands at $0.87 to $0.92, and non-GAAP diluted EPS guidance is $1.16 to $1.21, both on approximately 185 million weighted-average diluted shares. GAAP gross margin is expected at approximately 72%, with non-GAAP gross margin also approximately 72%. The company attributed the anticipated Q3 revenue inflection to the production ramp of the Scorpio X-Series 320-lane fabric switch.
Wall Street View
Analyst sentiment heading into the report leaned constructive, with the consensus as of August 1, 2026 skewed toward buy-side ratings. No specific price target changes were available in the source data at time of publication. Astera Labs also announced an expansion of its Taiwan operations and Cloud-Scale Interop Lab, which the company framed as a move to deepen engagement with key AI platform providers including AMD, Arm, Intel, and NVIDIA.
Investor Takeaway
The Q3 revenue guidance range of $540 million to $560 million, if achieved, would represent sequential growth exceeding the pace seen in Q2, suggesting the Scorpio X-Series ramp could sustain the company's double-digit quarterly revenue growth into the second half of 2026. The earlier-than-expected emergence of fabric switches as the largest product family also implies a potential shift in Astera Labs' revenue mix toward higher-complexity infrastructure products, which could carry implications for future gross margin trends as that ramp matures.
Editorial oversight by Teodora Hristova, Founder & Editor
Related Coverage
- Amgen (NASDAQ:AMGN) Posts Q2 2026 Beat, Raises Full-Year Revenue Outlook by $1BAMGN · Tuesday, August 4, 2026
- AMETEK (NYSE: AME) Posts Record Q2 2026 Sales of $2.04B, Raises Full-Year EPS GuidanceAME · Tuesday, August 4, 2026
- Assurant (NYSE: AIZ) Posts Record Q2 EPS of $6.41, Raises Full-Year 2026 OutlookAIZ · Tuesday, August 4, 2026
- Pfizer (NYSE: PFE) Q2 2026: $4.3B Impairment Masks Adjusted EPS Beat, Guidance RaisedPFE · Tuesday, August 4, 2026
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
